Program design spans eight educational tracks and more than 275 sessions, underscoring continued expansion of dermatology ...

Symptom control throughout three years: 86.1% of people living with moderate-to-severe hidradenitis suppurativa (HS) treated with BIMZELX had no acute ...

Investigational ZORYVE® (roflumilast) cream 0.05% was well tolerated with safety findings consistent with prior pediatric experience in the ...

Post hoc analyses of BIMZELX (bimekizumab-bkzx) using the first consensus definition of psoriasis on-treatment remission:Published by the National ...

What causes it, how it looks on different skin tones, and an available biologic treatment option that can be used with or ...

Detailed price information for Arcutis Biotherapeutics Inc (ARQT-Q) from The Globe and Mail including charting and trades.

Clinuvel unveils AI Vitiligo Visual Algorithm at AAD 2026, linking VVA to CUV107 Phase III; H1 FY26 revenue +4%, PAT -26% on ...

BEIJING, March 25, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced the annual ...

The Chinese biopharmaceutical company achieved profitability milestone in its full-year financial performance driven by drug sales growth.

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced the annual results ...

Eli Lilly and Company (NYSE: LLY) today announced detailed results from the TOGETHER-PsA open-label Phase 3b clinical trial evaluating the concomitant use of Taltz (ixekizumab) and Zepbound ...

The American Academy of Dermatology honored dermatologist and researcher Henry W. Lim, MD, FAAD, with the 2026 Gold Medal Award for more than 50 years of dedication and leadership in the specialty.The ...